Tiziana Life Sciences Ltd
NASDAQ:TLSA
Income Statement
Earnings Waterfall
Tiziana Life Sciences Ltd
Income Statement
Tiziana Life Sciences Ltd
| Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(13)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(10)
|
(10)
|
(30)
|
(43)
|
(27)
|
(14)
|
(15)
|
(19)
|
(18)
|
(16)
|
(16)
|
(18)
|
|
| Research & Development |
(10)
|
(6)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(4)
|
(4)
|
(3)
|
(6)
|
(11)
|
(13)
|
(15)
|
(13)
|
(9)
|
(8)
|
(7)
|
(5)
|
(6)
|
|
| Other Operating Expenses |
(4)
|
(4)
|
(6)
|
(6)
|
(5)
|
(5)
|
(4)
|
(5)
|
(6)
|
(7)
|
(24)
|
(32)
|
(14)
|
0
|
(2)
|
(10)
|
(10)
|
(8)
|
(11)
|
(13)
|
|
| Operating Income |
(13)
N/A
|
(10)
+22%
|
(10)
+4%
|
(11)
-17%
|
(11)
+7%
|
(11)
-4%
|
(10)
+11%
|
(9)
+6%
|
(10)
-7%
|
(10)
-2%
|
(30)
-201%
|
(43)
-42%
|
(27)
+37%
|
(14)
+47%
|
(15)
-1%
|
(19)
-29%
|
(18)
+4%
|
(16)
+12%
|
(16)
+0%
|
(18)
-17%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
(1)
|
(1)
|
4
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
(1)
|
(1)
|
0
|
(2)
|
(2)
|
1
|
|
| Pre-Tax Income |
(13)
N/A
|
(10)
+25%
|
(10)
+1%
|
(12)
-17%
|
(11)
+8%
|
(11)
-4%
|
(10)
+11%
|
(9)
+6%
|
(10)
-8%
|
(10)
-1%
|
(28)
-179%
|
(41)
-45%
|
(27)
+35%
|
(14)
+49%
|
(15)
-12%
|
(19)
-27%
|
(17)
+12%
|
(17)
+4%
|
(17)
-1%
|
(14)
+14%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
2
|
3
|
3
|
0
|
0
|
(0)
|
3
|
5
|
2
|
|
| Income from Continuing Operations |
(13)
|
(10)
|
(10)
|
(11)
|
(9)
|
(9)
|
(8)
|
(7)
|
(9)
|
(10)
|
(26)
|
(39)
|
(23)
|
(10)
|
(15)
|
(19)
|
(18)
|
(14)
|
(12)
|
(13)
|
|
| Net Income (Common) |
(13)
N/A
|
(10)
+25%
|
(10)
+2%
|
(11)
-17%
|
(9)
+23%
|
(9)
-5%
|
(8)
+13%
|
(7)
+7%
|
(9)
-26%
|
(10)
-2%
|
(26)
-174%
|
(39)
-49%
|
(23)
+40%
|
(10)
+55%
|
(15)
-47%
|
(19)
-27%
|
(18)
+9%
|
(14)
+22%
|
(12)
+14%
|
(13)
-8%
|
|
| EPS (Diluted) |
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.03
-50%
|
-0.05
-67%
|
-0.05
N/A
|
-0.05
N/A
|
-0.06
-20%
|
-0.31
-417%
|
-0.51
-65%
|
-0.24
+53%
|
-0.1
+58%
|
-0.15
-50%
|
-0.18
-20%
|
-0.17
+6%
|
-0.13
+24%
|
-0.11
+15%
|
-0.11
N/A
|
|